Form 4 for ELAN Elanco Animal Health Inc

Accepted 2021-12-02 00:00:00 ET · period of report 2021-11-30 · accession 0001179110-21-010539 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-12-02	2021-11-30	ELAN	BILBREY JOHN P	Dir	A - Grant	$0.00	+7,307	21.2K	+53%	$0
D	2021-12-02	2021-11-30	ELAN	BILBREY JOHN P	Dir	A - Grant	$28.74	+307.35	8,205	+4%	+$8,833

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-11-30	A	A	7,307	$0.00	21,208	D	—	—	(F1) Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.
2	Derivative	Deferred Stock Units	2021-11-30	A	A	307.35	$28.74	8,205.14	D	— · — to —	307.35 Common Stock	(F3) The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. (F2) Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. (F4) The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021.